An older man with gray hair, wearing a tan jacket and teal pants, walks alone down a colorful, empty street carrying a bag. Storefronts and palm trees line the sidewalk under a clear sky.

Fenben® Cancer Group Protocol (Quick Start)

Fenbendazole Protocol: Quick-Start Guide for Cancer Support

The Fenbendazole protocol has gained attention as a potential alternative treatment for those facing serious health challenges, particularly cancer. This protocol involves using Fenbendazole, a well-researched antiparasitic, along with other natural supplements to support overall health and potentially disrupt cancer cell growth. Many patients choose this protocol as a complementary therapy alongside traditional treatments. The Fenbendazole protocol offers a quick-start approach for individuals who need to begin treatment promptly and cannot commit to a longer, more detailed regimen.

1 Fenbendazole:

  • Start with 222 mg once daily. Gradually increase the dose to 1000 mg twice daily.
  • Always take Fenbendazole with food and fat for better absorption.

2 Tudca:

  • Take 500-1000 mg once or twice daily, on an empty stomach.

3 Serrapeptase or Modified Citrus Pectin (MCP):

  • Serrapeptase: Take 120,000-250,000 spu twice daily on an empty stomach. Do not take with other medications or supplements.
  • MCP: Take 15 grams daily on an empty stomach, also without other medications or supplements.
    (*If you are on blood thinners, use MCP instead of Serrapeptase.)

4 Multivitamin:

  • Take a Liposomal Multivitamin with Fenbendazole and food to maximize absorption.

Medical Disclaimers:
The Fenbendazole protocol is not FDA-approved for cancer treatment. Fenbendazole is a veterinary medication, and its effectiveness for treating cancer in humans is still under study. Always consult with a qualified healthcare provider before starting any new treatment, especially when considering alternative therapies. This protocol should be viewed as a complementary treatment, not a substitute for conventional cancer care.

sign-up for our newsletter